Form D · Biotechnology
UPTAKE MEDICAL CORP
Tustin, CA · CIK 0001316760
Offering snapshot reported Jan 5, 2016 · SEC filing
- Reported sold
- $2.4M Offering amount: $3.5M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 24, 2015 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$1,928,783 → $2,396,389
- Reported investors9 → 25
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 5, 2016 | Amendment | $2,396,389 | $467,606vs Dec 2, 2015 | 25 | SEC filing |
| Dec 2, 2015 | Initial | $1,928,783 | No comparison | 9 | SEC filing |
| Mar 13, 2012 | Amendment | $40,259,226 | $5,158,009vs Dec 27, 2011 | 38 | SEC filing |
| Dec 27, 2011 | Initial | $35,101,217 | No comparison | 37 | SEC filing |
| Jul 13, 2011 | Initial | $4,920,616 | No comparison | 35 | SEC filing |
| Aug 25, 2010 | Amendment | $16,892,420 | $12,310,212vs Oct 8, 2009 | 38 | SEC filing |
| Jun 2, 2010 | Initial | $600,600 | No comparison | 6 | SEC filing |
| Oct 8, 2009 | Amendment | $4,582,208 | $1,222,703vs Sep 11, 2009 | 33 | SEC filing |
| Sep 11, 2009 | Initial | $3,359,505 | No comparison | 6 | SEC filing |
| May 20, 2009 | Amendment | $3,136,333 | No comparison | Not reported | SEC filing |
| Jan 2, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 10, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 24, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 6, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 3, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-252272
Source: Form D, filed Jan 5, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Barry | Executive, Promoter |
| Geoff Brooke | Director |
| John Brooks | Director |
| Michael Hoey | Director |
| Scott Huennekens | Director |
| Eric Kim | Director |
| Robert Kuhling | Director |
| Robert Kuhling, Jr. | Director |
| J. C. Mac Rae | Executive |
| Krista Mann | Executive |
| R. King Nelson | Director, Executive |
| R. King Nelson | Director, Executive |
| Andrew Schiff | Director |
| Carl Simpson | Director |
| Carl Simson | Director |
| Sami Sindi | Director |
| David Singer | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1173 Warner Avenue
Tustin, CA, 92780
Tustin, CA, 92780